162 related articles for article (PubMed ID: 24608380)
1. Enhancement of antitumor immunity using a DNA-based replicon vaccine derived from Semliki Forest virus.
Zhang L; Wang Y; Xiao Y; Wang Y; Dong J; Gao K; Gao Y; Wang X; Zhang W; Xu Y; Yan J; Yu J
PLoS One; 2014; 9(3):e90551. PubMed ID: 24608380
[TBL] [Abstract][Full Text] [Related]
2. Synergistic antitumor efficacy of combined DNA vaccines targeting tumor cells and angiogenesis.
Yin X; Wang W; Zhu X; Wang Y; Wu S; Wang Z; Wang L; Du Z; Gao J; Yu J
Biochem Biophys Res Commun; 2015 Sep; 465(2):239-44. PubMed ID: 26253468
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of the immunogenicity of DNA replicon vaccine of Clostridium botulinum neurotoxin serotype A by GM-CSF gene adjuvant.
Li N; Yu YZ; Yu WY; Sun ZW
Immunopharmacol Immunotoxicol; 2011 Mar; 33(1):211-9. PubMed ID: 21284488
[TBL] [Abstract][Full Text] [Related]
4. [Construction of a replicative anti-tumor DNA vaccine PSCK-2PFcGB and its expression in vivo and in vitro].
Zhang L; Yan JQ; Wang Y; Xiao Y; Gao K; Dong JK; Wang B; Yu JY
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(6):937-42. PubMed ID: 21690041
[TBL] [Abstract][Full Text] [Related]
5. Induction of P815 tumor immunity by DNA-based recombinant Semliki Forest virus or replicon DNA expressing the P1A gene.
Ni B; Lin Z; Zhou L; Wang L; Jia Z; Zhou W; Diciommo DP; Zhao J; Bremner R; Wu Y
Cancer Detect Prev; 2004; 28(6):418-25. PubMed ID: 15582265
[TBL] [Abstract][Full Text] [Related]
6. Naked DNA immunization as an approach to target the generic tumor antigen survivin induces humoral and cellular immune responses in mice.
Lladser A; Párraga M; Quevedo L; Carmen Molina M; Silva S; Ferreira A; Billetta R; G Quest AF
Immunobiology; 2006; 211(1-2):11-27. PubMed ID: 16446167
[TBL] [Abstract][Full Text] [Related]
7. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells.
Cao X; Zhang W; Wang J; Zhang M; Huang X; Hamada H; Chen W
Immunology; 1999 Aug; 97(4):616-25. PubMed ID: 10457215
[TBL] [Abstract][Full Text] [Related]
8. Co-expression of granulocyte-macrophage colony-stimulating factor with antigen enhances humoral and tumor immunity after DNA vaccination.
Sun X; Hodge LM; Jones HP; Tabor L; Simecka JW
Vaccine; 2002 Jan; 20(9-10):1466-74. PubMed ID: 11818167
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
Stagg J; Wu JH; Bouganim N; Galipeau J
Cancer Res; 2004 Dec; 64(24):8795-9. PubMed ID: 15604233
[TBL] [Abstract][Full Text] [Related]
10. Enhancing immune responses using suicidal DNA vaccines.
Berglund P; Smerdou C; Fleeton MN; Tubulekas I; Liljeström P
Nat Biotechnol; 1998 Jun; 16(6):562-5. PubMed ID: 9624688
[TBL] [Abstract][Full Text] [Related]
11. Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity.
Avogadri F; Merghoub T; Maughan MF; Hirschhorn-Cymerman D; Morris J; Ritter E; Olmsted R; Houghton AN; Wolchok JD
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844763
[TBL] [Abstract][Full Text] [Related]
12. Semliki forest virus and Kunjin virus RNA replicons elicit comparable cellular immunity but distinct humoral immunity.
Tannis LL; Gauthier A; Evelegh C; Parsons R; Nyholt D; Khromykh A; Bramson JL
Vaccine; 2005 Jul; 23(33):4189-94. PubMed ID: 16005737
[TBL] [Abstract][Full Text] [Related]
13. Enhanced immunogenicity using an alphavirus replicon DNA vaccine against human immunodeficiency virus type 1.
Nordström EKL; Forsell MNE; Barnfield C; Bonin E; Hanke T; Sundström M; Karlsson GB; Liljeström P
J Gen Virol; 2005 Feb; 86(Pt 2):349-354. PubMed ID: 15659754
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy against metastatic bladder cancer by combined administration of granulocyte macrophage-colony stimulating factor and interleukin-2 surface modified MB49 bladder cancer stem cells vaccine.
Wang CY; Hua R; Liu L; Zhan X; Chen S; Quan S; Chu QJ; Zhu YT
Cancer Med; 2017 Mar; 6(3):689-697. PubMed ID: 28205361
[TBL] [Abstract][Full Text] [Related]
15. Gene immunotherapy in murine acute myeloid leukemia: granulocyte-macrophage colony-stimulating factor tumor cell vaccines elicit more potent antitumor immunity compared with B7 family and other cytokine vaccines.
Dunussi-Joannopoulos K; Dranoff G; Weinstein HJ; Ferrara JL; Bierer BE; Croop JM
Blood; 1998 Jan; 91(1):222-30. PubMed ID: 9414288
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and protective efficacy of Semliki forest virus replicon-based DNA vaccines encoding goatpox virus structural proteins.
Zheng M; Jin N; Liu Q; Huo X; Li Y; Hu B; Ma H; Zhu Z; Cong Y; Li X; Jin M; Zhu G
Virology; 2009 Aug; 391(1):33-43. PubMed ID: 19559453
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of Semliki Forest virus based self-amplifying RNA expressing Indian HIV-1C genes in mice.
Ajbani SP; Velhal SM; Kadam RB; Patel VV; Bandivdekar AH
Int J Biol Macromol; 2015 Nov; 81():794-802. PubMed ID: 26361864
[TBL] [Abstract][Full Text] [Related]
18. Induction of antigen-specific tumor immunity by genetic and cellular vaccines against MAGE: enhanced tumor protection by coexpression of granulocyte-macrophage colony-stimulating factor and B7-1.
Büeler H; Mulligan RC
Mol Med; 1996 Sep; 2(5):545-55. PubMed ID: 8898371
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of humoral and cellular immune responses to a DNA vaccine encoding chicken type II collagen for rheumatoid arthritis in normal rats.
Xiao Z; Juan L; Song Y; Zhijian Z; Jing J; Kun Y; Yuna H; Dongfa D; Lili D; Liuxin T; Fei L; Nan L; Fang Y; Yuying S; Yongzhi X
Hum Vaccin Immunother; 2015; 11(4):938-45. PubMed ID: 25763999
[TBL] [Abstract][Full Text] [Related]
20. Induction of PSA-specific CTLs and anti-tumor immunity by a genetic prostate cancer vaccine.
Roos AK; Pavlenko M; Charo J; Egevad L; Pisa P
Prostate; 2005 Feb; 62(3):217-23. PubMed ID: 15389792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]